Jeff Kindler, the now former CEO of Pfizer, was pressured by his board of directors to resign, sources tell me.
The concern of the board centered on Kindler's management style and was not primarily a result of the performance of the company or its stock price, though Pfizer's stock has not gained much during Kindler's tenure.
His decision to resign came after a continuing conversations with the board about the way Kindler managed the organization—choosing to micro-manage many issues as well as being a tough and difficult boss.
Of course, when the CEO of a massive company such as Pfizer resigns immediately, it is not often that the decision was their's alone.
Questions? Comments? Write to email@example.com.